Weiss Multi Strategy Advisers LLC Aurinia Pharmaceuticals Inc. Transaction History

Weiss Multi Strategy Advisers LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$6.66 - $12.39 $6,393 - $11,894	-960 Reduced 5.08%	17,922 $135,000
Q2 2022 Aug 15, 2022	SELL	$8.95 - $12.8 $8,914 - $12,748	-996 Reduced 5.01%	18,882 $190,000
Q1 2022 May 16, 2022	SELL	$10.05 - $22.48 $136,438 - $305,188	-13,576 Reduced 40.58%	19,878 $246,000
Q4 2021 Feb 14, 2022	SELL	$17.78 - $33.08 $2,471 - $4,598	-139 Reduced 0.41%	33,454 $765,000
Q3 2021 Nov 15, 2021	BUY	$10.93 - $23.55 $25,455 - $54,847	2,329 Added 7.45%	33,593 $743,000
Q2 2021 Aug 16, 2021	BUY	$10.0 - $14.52 $11,220 - $16,291	1,122 Added 3.72%	31,264 $405,000
Q1 2021 May 14, 2021	SELL	$12.3 - $18.73 $824 - $1,254	-67 Reduced 0.22%	30,142 $391,000
Q4 2020 Feb 16, 2021	BUY	$12.94 - $16.05 $129,904 - $161,125	10,039 Added 49.77%	30,209 $418,000
Q3 2020 Nov 16, 2020	BUY	$13.19 - $16.66 $266,042 - $336,032	20,170 New	20,170 $297,000

208

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.